http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103127413-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_653c418e41edbb4e1ce8bc5e53e70cec |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2013-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f7f94bac8614ff47c1c6528cbc6995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e84ef3a2690ee26ae7a6b94b711a949 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d0bc8e395837c3e9764c1778d4907ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9025b0f726ea50b3cc0f3d1bfa44afc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328d720fb088069cca5dd4f9cfb3ac2b |
| publicationDate | 2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103127413-B |
| titleOfInvention | Pharmaceutical preparation for treating coronary diseases |
| abstract | The invention discloses a pharmaceutical preparation for treating coronary diseases, and the pharmaceutical preparation is composed of the following bulk pharmaceutical chemicals in parts by weight: 20-30 parts of radix polygonati officinalis, 10-15 parts of cornus officinalis, 10-15 parts of uncaria rhynchophylla, 5-8 parts of fried spina date seeds,, 5-8 parts of platycodon grandiflorum, 20-30 parts of roots of straight ladybell, 30-40 parts of notoginseng, 25-35 parts of rhizoma ligustici wallichii, 15-30 parts of salvia miltiorrhiza, 10-15 parts of prepared rhizome of rehmannia, 10-20 parts of licorice roots, 10-20 parts of radix paeoniae alba, 5-15 parts of rhizoma imperatae, 20-35 parts of sangusis draconis, 15-25 parts of asarum, and 5-20 parts of humifuse euphorbia herbs. In the process of treatment, the pharmaceutical preparation is taken orally, one period of treatment lasts 10 days, the pharmaceutical preparation takes effect generally after one period of treatment, and after 2-3 periods of treatment, patients get better or are rehabilitated. The pharmaceutical preparation disclosed by the invention has the following advantages: 1, the pharmaceutical preparation is a pure natural Chinese herbal medicine, therefore, the pharmaceutical preparation is small in toxic and side effects and unique in therapeutic effect; and 2, the pharmaceutical preparation takes effect quickly and has an exact curative effect, and the clinical application of more than 600 patients verifies that the effective rate can reach 96.6%. |
| priorityDate | 2013-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335612 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452115392 |
Total number of triples: 18.